GAMMA Investing
CBIO icon

GAMMA Investing’s Crescent Biopharma CBIO Stock Holding History

GAMMA Investing’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.16K Buy
+148
New +$2.48K ﹤0.01% 3932

Other funds holding CBIO

Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

GAMMA Investing's CBIO Position: Q3 2026 in Review

GAMMA Investing opened a new position in Crescent Biopharma (CBIO) in Q3 2026: 148 shares worth $2.16K. The stake represents ﹤0.01% of the portfolio and ranks #3932 among its holdings.

5 funds tracked by Wall St. Rank hold CBIO as of Q3 2026.

  • GAMMA Investing held 148 shares of Crescent Biopharma worth $2.16K as of Q3 2026.
  • Crescent Biopharma was a new GAMMA Investing position in Q3 2026.
  • Crescent Biopharma made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3932 holding.
  • 5 funds tracked by Wall St. Rank held Crescent Biopharma as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.